Fatty liver is an independent predictor of early carotid atherosclerosis

被引:92
|
作者
Pais, Raluca [1 ]
Giral, Philippe [2 ]
Khan, Jean-Francois [2 ]
Rosenbaum, David [2 ]
Housset, Chantal [1 ]
Poynard, Thierry [1 ]
Ratziu, Vlad [1 ]
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, AP HP,ICAN, Serv Hepatogastroenterol,UMR S 938,INSERM CDR St, 47-83 Bd Hop, F-75013 Paris, France
[2] Univ Paris 06, INSERM, Hop La Pitie Salpetriere,UMR S 939, AP HP,Serv Endocrinol Metab,Unites Prevent Cardio, F-75013 Paris, France
关键词
Fatty liver; Atherosclerosis; Carotid intima-media thickness; Carotid plaques; Cardiovascular risk; Metabolic syndrome; Type; 2; diabetes; INTIMA-MEDIA THICKNESS; INCREASED ARTERIAL STIFFNESS; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; RISK-FACTORS;
D O I
10.1016/j.jhep.2016.02.023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Whether steatosis is incidentally or causally associated with carotid atherosclerosis is debated, and long-term follow-up data are missing. This study aims to examine the impact of steatosis on the presence and progression of carotid intima-media thickness (C-IMT) and carotid plaques (CP) in a large cohort with longitudinal follow-up. Methods: A retrospective single-center study between 1995 and 2012. Transversal cohort: patients with P2 cardiovascular risk factors without previous cardiovascular events. Longitudinal cohort: patients with two consecutive C-IMT measurements more than 2 years apart. Steatosis was defined by a surrogate marker, the fatty liver index (FLI). CP and C-IMT were assessed by carotid ultrasound. Results: In the transversal cohort (n = 5671) both C-IMT and the Framingham risk score (FRS) increased across FLI quartiles (0.58 +/- 0.12, 0.61 +/- 0.14, 0.63 +/- 0.14, 0.64 +/- 0.14 mm, and 5 +/- 5%, 9 +/- 7%, 12 +/- 8%, 15 +/- 9%, p < 0.001 for both). Steatosis predicted C-IMT better than diabetes or dyslipidemia. Steatosis independently predicted C-IMT (p = 0.002) and FRS (p < 0.001) after adjustment for metabolic syndrome and cardiovascular risk factors. In the longitudinal cohort (n = 1872, mean follow-up 8 +/- 4 years), steatosis occurred in 12% and CP in 23% of patients. C-IMT increased in patients with steatosis occurrence (from 0.60 +/- 0.13 mm to 0.66 +/- 0.14 mm, p = 0.001) whereas it did not change in those that stayed free of steatosis. Steatosis at baseline predicted CP occurrence (OR = 1.63, 95% CI 1.10-2.41, p = 0.014), independent of age, sex, type-2 diabetes, tobacco use, hsCRP, hypertension and C-IMT. Conclusions: In patients with metabolic syndrome at risk for cardiovascular events, steatosis contributes to early atherosclerosis and progression thereof, independent of traditional cardiovascular risk factors. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 50 条
  • [41] An update on markers of carotid atherosclerosis in patients with Type 2 diabetes
    Kadoglou, Nikolaos P. E.
    Avgerinos, Efthimios D.
    Liapis, Christos D.
    BIOMARKERS IN MEDICINE, 2010, 4 (04) : 601 - 609
  • [42] The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort
    Dick, Taylor J. M.
    Lesser, Iris A.
    Leipsic, Jonathon A.
    Mancini, G. B. John
    Lear, Scott A.
    ATHEROSCLEROSIS, 2013, 226 (01) : 208 - 213
  • [43] Metabolic Syndrome Is Correlated With Carotid Atherosclerosis in Patients With Lupus Nephritis
    Zhang, Minfang
    Qi, Chaojun
    Cao, Liou
    Qian, Jiaqi
    Ni, Zhaohui
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (06) : 486 - 491
  • [44] Abnormal Liver Function Tests and Metabolic Syndrome-Is Fatty Liver Related to Risks for Atherosclerosis beyond Obesity?
    Sakurai, Masaru
    Takamura, Toshinari
    Miura, Katsuyuki
    Kaneko, Shuichi
    Nakagawa, Hideaki
    INTERNAL MEDICINE, 2009, 48 (18) : 1573 - 1574
  • [45] Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese
    Huang, Yun
    Bi, Yufang
    Xu, Min
    Ma, Zhimin
    Xu, Yu
    Wang, Tiange
    Li, Mian
    Liu, Yu
    Lu, Jieli
    Chen, Yuhong
    Huang, Fei
    Xu, Baihui
    Zhang, Jie
    Wang, Weiqing
    Li, Xiaoying
    Ning, Guang
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (09) : 2321 - 2326
  • [46] Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
    DeFilippis, Andrew Paul
    Blaha, Michael J.
    Martin, Seth S.
    Reed, Robert M.
    Jones, Steven R.
    Nasir, Khurram
    Blumenthal, Roger S.
    Budoff, Matthew J.
    ATHEROSCLEROSIS, 2013, 227 (02) : 429 - 436
  • [47] The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease
    Margariti, Aikaterini
    Deutsch, Melanie
    Manolakopoulos, Spilios
    Tiniakos, Dina
    Papatheodoridis, George V.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 280 - 286
  • [48] Presarcopenia Is an Independent Risk Factor for Carotid Atherosclerosis in Chinese Population with Metabolic Syndrome
    Cao, Yuan
    Zhong, Ming
    Zhang, Yuke
    Zheng, Zijie
    Liu, Yapeng
    Ni, Xiaoning
    Han, Lu
    Song, Ming
    Zhang, Wei
    Wang, Zhihao
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 81 - 88
  • [49] The Cardiovascular Link to Nonalcoholic Fatty Liver Disease A Critical Analysis
    Pacana, Tommy
    Fuchs, Michael
    CLINICS IN LIVER DISEASE, 2012, 16 (03) : 599 - +
  • [50] Fatty Liver Is Associated with Insulin Resistance, Risk of Coronary Heart Disease, and Early Atherosclerosis in a Large European Population
    Gastaldelli, Amalia
    Kozakova, Michaela
    Hojlund, Kurt
    Flyvbjerg, Allan
    Favuzzi, Angela
    Mitrakou, Asimina
    Balkau, Beverley
    HEPATOLOGY, 2009, 49 (05) : 1537 - 1544